13,232 reports of this reaction
1.9% of all ALBUTEROL SULFATE reports
#10 most reported adverse reaction
WHEEZING is the #10 most commonly reported adverse reaction for ALBUTEROL SULFATE, manufactured by Aurobindo Pharma Limited. There are 13,232 FDA adverse event reports linking ALBUTEROL SULFATE to WHEEZING. This represents approximately 1.9% of all 683,072 adverse event reports for this drug.
Patients taking ALBUTEROL SULFATE who experience wheezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WHEEZING is a less commonly reported adverse event for ALBUTEROL SULFATE, but still significant enough to appear in the safety profile.
In addition to wheezing, the following adverse reactions have been reported for ALBUTEROL SULFATE:
The following drugs have also been linked to wheezing in FDA adverse event reports:
WHEEZING has been reported as an adverse event in 13,232 FDA reports for ALBUTEROL SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
WHEEZING accounts for approximately 1.9% of all adverse event reports for ALBUTEROL SULFATE, making it a notable side effect.
If you experience wheezing while taking ALBUTEROL SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.